• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pH对呋塞米从聚酰胺-胺(PAMAM)树枝状大分子复合物中的溶解度和释放的影响。

Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes.

作者信息

Devarakonda Bharathi, Otto Daniel P, Judefeind Anja, Hill Ronald A, de Villiers Melgardt M

机构信息

School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.

出版信息

Int J Pharm. 2007 Dec 10;345(1-2):142-53. doi: 10.1016/j.ijpharm.2007.05.039. Epub 2007 May 24.

DOI:10.1016/j.ijpharm.2007.05.039
PMID:17600643
Abstract

The complexation of the practically insoluble drug furosemide (acidic pK(a) 3.22) with lower generation PAMAM dendrimers showed a significant release dependence on the ionization state of the drug. UV and FTIR studies suggested that the drug was localized in the interior of the dendrimer. The dendrimer amine, amide and ester groups, demonstrated pH-dependent ionization as did the drug carboxylic acid group and it was proven that the most efficient drug complexation was achieved in slightly acidic conditions (pH 4.0-6.0). At this pH, amide groups in the dendrimer cavities were at least partially ionized to expose a positive charge whilst the furosemide carboxylic acid ionized to great extent (pH>pK(a)) resulting in electrostatic complexation. Conversely, higher release rates were observed in acidic conditions (pH 1.2) where furosemide was virtually unionized, emphasizing the importance of the drug ionization state in the determination of drug release. Despite the complex interactions between the dendrimer and drug and its effects on release kinetics, the dendrimers resulted in higher solubility of the drug and contributed significantly to the array of available techniques to increase the solubility of poorly water-soluble drugs that are very abundant in industry today. Complexation with low generation PAMAM dendrimers (<generation 4) could provide opportunities to both increase drug solubility and tuning of the release profile for practically insoluble drugs.

摘要

几乎不溶的药物呋塞米(酸性pK(a) 3.22)与低代数聚酰胺-胺(PAMAM)树枝状大分子的络合显示出药物释放对其电离状态有显著依赖性。紫外和傅里叶变换红外光谱(FTIR)研究表明,药物定位于树枝状大分子内部。树枝状大分子的胺基、酰胺基和酯基与药物的羧酸基团一样表现出pH依赖性电离,并且已证明在微酸性条件(pH 4.0 - 6.0)下可实现最有效的药物络合。在此pH值下,树枝状大分子空腔中的酰胺基至少部分电离以暴露正电荷,而呋塞米羧酸则大量电离(pH > pK(a)),从而导致静电络合。相反,在酸性条件(pH 1.2)下观察到更高的释放速率,此时呋塞米几乎未电离,这强调了药物电离状态在药物释放测定中的重要性。尽管树枝状大分子与药物之间存在复杂的相互作用及其对释放动力学的影响,但树枝状大分子提高了药物的溶解度,并对当今工业中大量存在的水溶性差的药物增加溶解度的一系列现有技术做出了重大贡献。与低代数PAMAM树枝状大分子(<第4代)络合可为提高几乎不溶药物的溶解度和调节释放曲线提供机会。

相似文献

1
Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes.pH对呋塞米从聚酰胺-胺(PAMAM)树枝状大分子复合物中的溶解度和释放的影响。
Int J Pharm. 2007 Dec 10;345(1-2):142-53. doi: 10.1016/j.ijpharm.2007.05.039. Epub 2007 May 24.
2
Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins.聚酰胺 - 胺(PAMAM)树枝状大分子和环糊精对实际难溶的氯硝柳胺的水相增溶作用比较。
Int J Pharm. 2005 Nov 4;304(1-2):193-209. doi: 10.1016/j.ijpharm.2005.07.023. Epub 2005 Sep 27.
3
Solubility of nicotinic acid in polyamidoamine dendrimer solutions.烟酸在聚酰胺胺树枝状大分子溶液中的溶解度。
Eur J Med Chem. 2005 Dec;40(12):1384-9. doi: 10.1016/j.ejmech.2005.08.001. Epub 2005 Oct 13.
4
Computationally efficient methodology for atomic-level characterization of dendrimer-drug complexes: a comparison of amine- and acetyl-terminated PAMAM.用于树枝状聚合物-药物复合物原子水平表征的计算高效方法:胺基和乙酰基封端的 PAMAM 的比较。
J Phys Chem B. 2013 Jun 6;117(22):6801-13. doi: 10.1021/jp4000363. Epub 2013 May 22.
5
Polyamidoamine Starburst dendrimers as solubility enhancers.聚酰胺-胺型树枝状大分子作为增溶剂
Int J Pharm. 2000 Mar 20;197(1-2):239-41. doi: 10.1016/s0378-5173(99)00463-9.
6
Polyamidoamine dendrimers used as solubility enhancers of ketoprofen.用作酮洛芬溶解度增强剂的聚酰胺-胺树枝状大分子。
Eur J Med Chem. 2005 Dec;40(12):1390-3. doi: 10.1016/j.ejmech.2005.08.002. Epub 2005 Oct 13.
7
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.树枝状大分子和超支化聚合物的药物络合、体外释放及细胞摄取
Int J Pharm. 2003 Jun 18;259(1-2):143-60. doi: 10.1016/s0378-5173(03)00225-4.
8
Synthesis of Polyamidoamine Dendrimer for Encapsulating Tetramethylscutellarein for Potential Bioactivity Enhancement.用于包裹黄芩苷以增强潜在生物活性的聚酰胺-胺树枝状大分子的合成。
Int J Mol Sci. 2015 Nov 4;16(11):26363-77. doi: 10.3390/ijms161125956.
9
PAMAM dendrimers for the delivery of the antibacterial Triclosan.用于递送抗菌剂三氯生的聚酰胺-胺树形聚合物
J Enzyme Inhib Med Chem. 2008 Oct;23(5):623-8. doi: 10.1080/14756360802205257.
10
Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes.通过与4-磺酸杯[n]芳烃形成超分子络合物实现速尿的水相增溶。
J Pharm Pharmacol. 2004 Jun;56(6):703-8. doi: 10.1211/0022357023439.

引用本文的文献

1
Development of a quaternary ammonium poly (amidoamine) dendrimer-based drug carrier for the solubility enhancement and sustained release of furosemide.基于季铵化聚(酰胺胺)树枝状大分子的呋塞米增溶及缓释药物载体的研发。
Front Chem. 2023 Feb 17;11:1123775. doi: 10.3389/fchem.2023.1123775. eCollection 2023.
2
Quantum and Classical Evaluations of Carboxylic Acid Bioisosteres: From Capped Moieties to a Drug Molecule.羧酸生物电子等排体的量子与经典评估:从封端基团到药物分子
ACS Omega. 2022 Dec 19;8(1):588-598. doi: 10.1021/acsomega.2c05708. eCollection 2023 Jan 10.
3
Pharmacokinetics and diuretic effect of furosemide after single intravenous, oral tablet, and newly developed oral disintegrating film administration in healthy beagle dogs.
在健康比格犬中单静脉注射、口服片剂和新开发的口服分散片给药后,呋塞米的药代动力学和利尿作用。
BMC Vet Res. 2021 Sep 6;17(1):295. doi: 10.1186/s12917-021-02998-4.
4
Use of Half-Generation PAMAM Dendrimers (G0.5-G3.5) with Carboxylate End-Groups to Improve the DACHPtCl and 5-FU Efficacy as Anticancer Drugs.使用带羧酸盐端基的半代 PAMAM 树状大分子(G0.5-G3.5)提高 DACHPtCl 和 5-FU 的疗效作为抗癌药物。
Molecules. 2021 May 14;26(10):2924. doi: 10.3390/molecules26102924.
5
Enhanced sustained release of furosemide in long circulating chitosan-conjugated PLGA nanoparticles.速尿在长循环壳聚糖共轭聚乳酸-羟基乙酸共聚物纳米粒中的缓释增强
Res Pharm Sci. 2019 Mar 8;14(2):93-106. doi: 10.4103/1735-5362.253356. eCollection 2019 Apr.
6
Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability.一种以舌下生物粘附膜形式存在的速尿无定形固体分散体的开发与表征,以提高生物利用度。
Pharmaceutics. 2017 Jun 24;9(3):22. doi: 10.3390/pharmaceutics9030022.
7
Enhanced photodynamic efficacy and efficient delivery of Rose Bengal using nanostructured poly(amidoamine) dendrimers: potential application in photodynamic therapy of cancer.使用纳米结构聚(酰胺胺)树枝状大分子增强孟加拉玫瑰红的光动力疗效及有效递送:在癌症光动力治疗中的潜在应用
Cancer Nanotechnol. 2011;2(1-6):95-103. doi: 10.1007/s12645-011-0019-3. Epub 2011 Aug 13.
8
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues.树枝状大分子在药物递送与靶向中的应用:药物 - 树枝状大分子相互作用及毒性问题
J Pharm Bioallied Sci. 2014 Jul;6(3):139-50. doi: 10.4103/0975-7406.130965.
9
Validated reverse-phase high-performance liquid chromatography for quantification of furosemide in tablets and nanoparticles.反相高效液相色谱法验证定量片剂和纳米粒中的呋塞米。
J Anal Methods Chem. 2013;2013:207028. doi: 10.1155/2013/207028. Epub 2013 Sep 16.
10
Evaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy.利用溶解度研究和二维核Overhauser效应光谱法评估聚(酰胺胺)树枝状大分子作为亚氨基二乙酸衍生物潜在载体的性能。
J Biol Phys. 2012 Sep;38(4):637-56. doi: 10.1007/s10867-012-9277-5. Epub 2012 Aug 16.